Diabetes and pregnancy

Joslin's Diabetes Mellitus: Fourteenth Edition

Volumn , Issue , 2011, Pages 1035-1047

  Brown, Florence M ^a,b   Goldfine, Allison B ^a,b  

^a JOSLIN DIABETES CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84971010923     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (132)

1. O'Sullivan J, Mahan CM. Criteria for the oral glucose tolerance test in pregnancy. Diabetes 1964;13:278-285.
2. ACOG Practice Bulletin. Clinical management guidelines for obstetriciangynecologists. Number 30, September 2001 (replaces Technical Bulletin no. 200, December 1994). Gestational diabetes. Obstet Gynecol 2001;98:525-538.
3. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2004;27[Suppl 1]:S88-S90.
4. World Health Organization: WHO Expert Committee on Diabetes Mellitus. Second Report. Technical Report Series, no. 646. Geneva: World Health Organization, 1980.
5. Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the U.S.: 1990-1998. Diabetes Care 2000;23:1278-1283.
6. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 1998;21[Suppl 2]:B161-B167.
7. Elixhauser A, Weschler JM, Kitzmiller JL, et al. Cost-benefit analysis of preconception care for women with established diabetes mellitus. Diabetes Care 1993;16:1146-1157.
8. White P. Pregnancy complicating diabetes. Am J Med 1949;7:609-616.
9. Hare J, White P. Gestational diabetes and the White classification. Diabetes Care 1980;3:394.
10. Warram J, Krolewski AS. Use of the albumin/creatinine ratio in patient care and clinical studies. In: Morgens CE, ed. The kidney and hypertension in diabetes mellitus. Boston: Kluwer Academic Publishers, 1998:85-96.
11. Kitzmiller JL, Brown ER, Phillippe M, et al. Diabetic nephropathy and perinatal outcome. Am J Obstet Gynecol 1981;141:741-751.
12. Greene MF, Hare JW, Krache M, et al. Prematurity among insulin-requiring diabetic gravid women. Am J Obstet Gynecol 1989;161:106-111.
13. Reece EA, Coustan DR, Hayslett JP, et al. Diabetic nephropathy: pregnancy performance and fetomaternal outcome. Am J Obstet Gynecol 1988;15:56-66.
14. Dunne F, Chowdhur TA, Hartland A, et al. Pregnancy outcome in women with insulin-dependent diabetes mellitus complicated by nephropathy. . J Med 1999;92:451-454.
15. Grenfell A, Brudenell JM, Doddridge MC, et al. Pregnancy in diabetic women who have proteinuria. . J Med 1986;59:379-386.
16. Rosenn B, Miodovnik M, Khoury JC. Outcome of pregnancy in women with diabetic nephropathy. Am J Obstet Gynecol 1997;176:S179.
17. Kimmerle R, Zass RP, Cupisti S, et al. Pregnancies in women with diabetic nephropathy: long-term outcome for mother and child. Diabetologia 1995;38: 227-235.
18. Gordon M, Landon MB, Samuels P, et al. Perinatal outcome and long-term follow-up associated with modern management of diabetic nephropathy. Obstet Gynecol 1996;87:401-409.
19. Reece EA, Leguizamon G, Homko C. Stringent controls in diabetic nephropathy associated with optimization of pregnancy outcomes. . Matern Fetal Med 1998;7:213-216.
20. Rosenn BM, Miodovnik M. Medical complications of diabetes mellitus in pregnancy. Clin Obstet Gynecol 2000;43:17-31.
21. Reece EA, Leguizamon G, Homko C. Pregnancy performance and outcomes associated with diabetic nephropathy. Am J Perinatol 1998;15:413-421.
22. Combs CA, Rosenn B, Kitzmiller JL, et al. Early-pregnancy proteinuria in diabetes related to preeclampsia. Obstet Gynecol 1993;82:802-807.
23. Ekbom P. Pre-pregnancy microalbuminuria predicts pre-eclampsia in insulin-dependent diabetes mellitus. Copenhagen Pre-eclampsia in Diabetic Pregnancy Study Group. Lancet 1999;353:377.
24. Schroder W, Heyl W, Hill-Grasshoff B, et al. Clinical value of detecting microalbuminuria as a risk factor for pregnancy-induced hypertension in insulin-treated diabetic pregnancies. Eur J Obstet Gynecol Reprod Biol 2000;91: 155-158.
25. Centers for Disease Control. Perinatal mortality and congenital malformations in infants born to women with insulin-dependent diabetes mellitus-United States, Canada, and Europe, 1940-1988. JAMA 1990;264:437-441.
26. Lawrence R, Oakle W. Pregnancy and diabetes. . J Med 1942;11:45-75.
27. Kucera J. Rate and type of congenital anomalies among offspring of diabetic women. . Reprod Med 1971;7:73-82.
28. Greene MF. Prevention and diagnosis of congenital anomalies in diabetic pregnancies. Clin Perinatol 1993;20:533-547.
29. Mills JL, Baker L, Goldman AS. Malformations in infants of diabetic mothers occur before the seventh gestational week. Implications for treatment. Diabetes 1979;28:292-293.
30. Opitz JM. Blastogenesis and the "primary field" in human development. Birth Defects Original Article Series 1993;29:3-37.
31. Leslie R, Pyke DA, John PN, et al. Hemoglobin A1 in diabetic pregnancy. Lancet 1978;2:958-959.
32. Miller E, Hare JW, Cloherty JP, et al. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. . Engl J Med 1981;304:1331-1334.
33. Greene M, Hare JW, Cloherty JP, et al. First trimester hemoglobin A1 and risk for major malformations. Teratology 1989;39:225-331.
34. Kitzmiller JL, Buchanan TA, Kjos S, et al. Pre-conception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care 1996;19: 514-541.
35. Ylinen K, Aula P, Stenman UH, et al. Risk of minor and major fetal malformations in diabetics with high haemoglobin A1c values in early pregnancy. BMJ (Clin Res Ed) 1984;289:345-346.
36. Reid M, Hadden D, Harley JM, et al. Fetal malformations in diabetics with high haemoglobin A1c in early pregnancy [Letter]. BMJ (Clin Res Ed) 1984;289: 1001.
37. Key TC, Giuffrida R, Moore TR. Predictive value of early pregnancy glycohemoglobin in the insulin-treated diabetic patient. Am J Obstet Gynecol 1987; 156:1096-1100.
38. Hanson U, Persson B, Thunell S. Relationship between haemoglobin 1Ac in early type 1 (insulin-dependent) diabetic pregnancy and the occurrence of spontaneous abortion and fetal malformation in Sweden. Diabetologia 1990; 33:100-104.
39. Rosenn BM, Miodovnik M, Combs CA, et al. Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol 1994;84:515-520.
40. Fuhrmann K, Reiher H, Semmler K, et al. Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care 1983; 6:219-223.
41. Fuhrmann K, Reiher H, Semmler K, et al. The effect of intensified conventional insulin therapy before and during pregnancy on the malformation rate in offspring of diabetic mothers. Exp Clin Endocrinol 1984;83:173-177.
42. Goldman JA, Dicker D, Feldberg D, et al. Pregnancy outcome in patients with insulin-dependent diabetes mellitus with preconceptional diabetic control: a comparative study. Am J Obstet Gynecol 1986;155:293-297.
43. Damm P, Molsted-Pedersen L. Significant decrease in congenital malformations in newborn infants of an unselected population of diabetic women. Am J Obstet Gynecol 1989;161:1163-1167.
44. Steel JM, Johnstone FD, Hepburn DA, et al. Can prepregnancy care of diabetic women reduce the risk of abnormal babies? BMJ 1990;301:1070-1074.
45. Kitzmiller JL, Gavin LA, Gin GD, et al. Preconception care of diabetes. Glycemic control prevents congenital anomalies. JAMA 1991;265:731-736.
46. Rosenn B, Miodovnik M, Combs CA, et al. Pre-conception management of insulin-dependent diabetes: improvement of pregnancy outcome. Obstet Gynecol 1991;77:846-849.
47. Tchobroutsky C, Vray MM, Altman JJ. Risk/benefit ratio of changing late obstetrical strategies in the management of insulin-dependent diabetic pregnancies. A comparison between 1971-1977 and 1978-1985 periods in 389 pregnancies. Diabete Metab 1991;17:287-294.
48. Willhoite MB, Bennert HW Jr, Palomaki GE, et al. The impact of preconception counseling on pregnancy outcomes. The experience of the Maine Diabetes in Pregnancy Program. Diabetes Care 1993;16:450-455.
49. Holing EV, Beyer CS, Brown ZA, et al. Why don't women with diabetes plan their pregnancies? Diabetes Care 1998;21:889-895.
50. Jovanovic-Peterson L, Peterson CM, Reed GF, et al. Maternal postprandial glucose levels and infant birth weight: the Diabetes in Early Pregnancy Study. The National Institute of Child Health and Human Development-Diabetes in Early Pregnancy Study. Am J Obstet Gynecol 1991;164(1 Pt 1):103-111.
51. Rey E, Attie C, Bonin A. The effects of first-trimester diabetes control on the incidence of macrosomia. Am J Obstet Gynecol 1999;181:202-206.
52. Gold AE, Reilly R, Little J, et al. The effect of glycemic control in the preconception period and early pregnancy on birth weight in women with IDDM. Diabetes Care 1998;21:535-538.
53. Peck RW, Price DE, Lang GD, et al. Birthweight of babies born to mothers with type 1 diabetes: is it related to blood glucose control in the first trimester? Diabet Med 1991;8:258-262.
54. Schwartz R, Gruppuso PA, Petzold K, et al. Hyperinsulinemia and macrosomia in the fetus of the diabetic mother. Diabetes Care 1994;17:640-648.
55. Small M, Cameron A, Lunan CB, et al. Macrosomia in pregnancy complicated by insulin-dependent diabetes mellitus. Diabetes Care 1987;10:594-599.
56. Combs CA, Gunderson E, Kitzmiller JL, et al. Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care 1992;15:1251-1257.
57. Pederson J. Weight and length at birth of infants of diabetic mothers. Acta Endocrinol 1954;16:330-342.
58. Cordero L, Treuer SH, Landon MB, et al. Management of infants of diabetic mothers. Arch Pediatr Adolesc Med 1998;152:249-254.
59. Landon MB, Gabbe SG, Piana R, et al. Neonatal morbidity in pregnancy complicated by diabetes mellitus: predictive value of maternal glycemic profiles. Am J Ostet Gynecol 1987;156:1089-1095.
60. Curet LB, Izquierdo LA, Gilson GJ, et al. Relative effects of antepartum and intrapartum maternal blood glucose levels on incidence of neonatal hypoglycemia. . Perinatol 1997;17:113-115.
61. Combs CA, Kitzmiller JL. Diabetic nephropathy and pregnancy. Clin Obstet Gynecol 1991;34:505-515.
62. Leguizamon G, Reece EA. Effect of medical therapy on progressive nephropathy: influence of pregnancy, diabetes and hypertension. . Matern Fetal Med 2000;9:70-78.
63. Kimmerle R, Heinemann L, Delecki A, et al. Severe hypoglycemia incidence and predisposing factors in 85 pregnancies of type I diabetic women. Diabetes Care 1992;15:1034-1047.
64. Rosenn BM, Miodovnik M, Holcberg G, et al. Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus. Obstet Gynecol 1995;85:417-422.
65. Anderson JH Jr, Brunelle RL, Koivisto VA, et al. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulinanalog treatment. Multicenter Insulin Lispro Study Group. Diabetes 1997;46: 265-270.
66. Brunelle BL, Llewelyn J, Anderson JH Jr, et al. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care 1998;21:1726-1731.
67. Del Sindaco P, Ciofetta M, Lalli C, et al. Use of the short-acting insulin analogue lispro in intensive treatment of type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal. Diabet Med 1998;15:592-600.
68. Ebeling P, Jansson PA, Smith U, et al. Strategies toward improved control during insulin lispro therapy in IDDM. Importance of basal insulin. Diabetes Care 1997;20:1287-1289.
69. Colombel A, Murat A, Krempf M, et al. Improvement of blood glucose control in type 1 diabetic patients treated with lispro and multiple NPH injections. Diabet Med 1999;16:319-324.
70. Hermansen K, Colombo M, Storgaard H, et al. Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes. Diabetes Care 2002;25:883-888.
71. Jovanovic L, Ilic S, Pettitt DJ, et al. Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care 1999;22:1422-1227.
72. Pettitt DJ, Ospina P, Kolaczynski JW, et al. Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus. Diabetes Care 2003;26:183-186.
73. Kurtzhals P, Schaffer L, Sorensen A, et al. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 2000;49:999-1005.
74. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183(1): S1-S22.
75. Summary of Revisions for the 2001 Clinical Practice Recommendations. Diabetes Care 2001;24[Suppl 1]:S3.
76. von Dadelszen P, Ornstein MP, Bull SB, et al. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 2000;355:87-92.
77. Magee LA, Elran E, Bull SB, et al. Risks and benefits of beta-receptor blockers for pregnancy hypertension: overview of the randomized trials. Eur J Obstet Gynecol Reprod Biol 2000;88:15-26.
78. Briggs CG, Freeman RK, Yafee SJ. Drugs in pregnancy and lactation. Vol. 6. Philadelphia: Lippincott Williams & Wilkins, 2002:174-181, 469-476.
79. Krolewski AS, Warram JH, Christlieb AR, et al. The changing natural history of nephropathy in type I diabetes. Am J Med 1985;78:785-794.
80. Zatz R, Meyer TW, Rennke HG, et al. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U S A 1985;82:5963-5967.
81. Mogensen CE. Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. Scand J Clin Lab Invest 1986;46:201-206.
82. McCance DR, Traub AI, Harley JM, et al. Urinary albumin excretion in diabetic pregnancy. Diabetologia 1989;32:236-239.
83. Hod M, van Dijk DJ, Karp M, et al. Diabetic nephropathy and pregnancy: the effect of ACE inhibitors prior to pregnancy on fetomaternal outcome. Nephrol Dial Transplant 1995;10:2328-2333.
84. Chew EY, Mills JL, Metzger BE, et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Diabetes Care 1995;18:631-637.
85. The Diabetes Control and Complications Trial Research Group. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. Diabetes Care 2000;23:1084-1091.
86. American Diabetes Association. Clinical practice recommendations. Preconception care of women with diabetes. Diabetes Care 2004;27[Suppl]: S76-S78.
87. Brown FM, Hare JW. Diabetic neuropathy and coronary heart disease. In: Reece EA, Coustan DR, eds. Diabetes mellitus in pregnancy. Principles and practice. New York: Churchill Livingstone, 1995:345-351.
88. Krolewski AS, Kosinski EJ, Warram JH, et al. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 1987;59:750-755.
89. Consensus Development Conference on the Diagnosis of Coronary Heart Disease in People with Diabetes: 10-11 February 1998, Miami, Florida. American Diabetes Association. Diabetes Care 1998;21:1551-1559.
90. Hsia SH, Connelly PW, Hegele RA. Successful outcome in severe pregnancyassociated hyperlipemia: a case report and literature review. Am J Med Sci 1995;309:213-218.
91. Loo CC, Tan JY. Decreasing the plasma triglyceride level in hypertriglyceridemia-induced pancreatitis in pregnancy: a case report. Am J Obstet Gynecol 2002;187:241-242.
92. Mizushimat T, Ochi K, Matsumura N, et al. Prevention of hyperlipidemic acute pancreatitis during pregnancy with medium-chain triglyceride nutritional support. Int J Pancreatol 1998;23:187-192.
93. ACOG Practice Bulletin. Chronic hypertension in pregnancy. Obstet Gynecol 2001;98:177-184.
94. Kjos SL. Postpartum care of the woman with diabetes. Clin Obstet Gynecol 2000;43:75-86.
95. Metzger BE. Summary and recommendations of the Third International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes 1991;40 [Suppl 2]:197-201.
96. Duncan M. On puerperal diabetes. Trans Obstet Soc Lond 1882;256-285(24).
97. Engelgau MM, Herman WH, Smith PJ, et al. The epidemiology of diabetes and pregnancy in the U.S., 1988. Diabetes Care 1995;18:1029-1033.
98. Green JR, Pawson IG, Schumacher LB, et al. Glucose tolerance in pregnancy: ethnic variation and influence of body habitus. Am J Obstet Gynecol 1990;163 (1 Pt 1):86-92.
99. Kuhl C. Glucose metabolism during and after pregnancy in normal and gestational diabetic women. 1. Influence of normal pregnancy on serum glucose and insulin concentration during basal fasting conditions and after a challenge with glucose. Acta Endocrinol (Copenh) 1975;79:709-719.
100. Damm P, Kuhl C, Bertelsen A, et al. Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus. Am J Obstet Gynecol 1992;167:607-616.
101. Catalano PM, Tyzbir ED, Wolfe RR, et al. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol 1993;264(1 Pt 1):E60-E67.
102. Bowes SB, Hennessy TR, Umpleby AM, et al. Measurement of glucose metabolism and insulin secretion during normal pregnancy and pregnancy complicated by gestational diabetes. Diabetologia 1996;39:976-983.
103. Swinn RA, Wareham NJ, Gregory R, et al. Excessive secretion of insulin precursors characterizes and predicts gestational diabetes. Diabetes 1995;44: 911-915.
104. Kuhl C. Serum proinsulin in normal and gestational diabetic pregnancy. Diabetologia 1976;12:295-300.
105. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;18:1039-1057.
106. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768-773.
107. ADAExpert Committee on the Diagnosis and Classification of Diabetes Mellitus, Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Clinical Practice Recommendations 2000. Diabetes Care 2000[Suppl 1]:S4-S19.
108. Coustan DR, Nelson C, Carpenter MW, et al. Maternal age and screening for gestational diabetes: a population-based study. Obstet Gynecol 1989;73: 557-561.
109. Berkus MD, Langer O. Glucose tolerance test: degree of glucose abnormality correlates with neonatal outcome. Obstet Gynecol 1993;81:344-348.
110. Sermer M, Naylor CD, Farine D, et al. The Toronto Tri-Hospital Gestational Diabetes Project. A preliminary review. Diabetes Care 1998;21[Suppl 2]: B33-B42.
111. Moses RG, Calvert D. Pregnancy outcomes in women without gestational diabetes mellitus related to the maternal glucose level. Is there a continuum of risk? Diabetes Care 1995;18:1527-1533.
112. Drexel H, Bichler A, Sailer S, et al. Prevention of perinatal morbidity by tight metabolic control in gestational diabetes mellitus. Diabetes Care 1988;11: 761-768.
113. Langer O, Levy J, Brustman L, et al. Glycemic control in gestational diabetes mellitus-how tight is tight enough: small for gestational age versus large for gestational age? Am J Obstet Gynecol 1989;161:646-653.
114. Jovanovic-Peterson L. Medical management of pregnancy complicated by diabetes, 2nd ed. Alexandria, VA: American Diabetes Association, 1995.
115. Clapp JF 3rd. Maternal carbohydrate intake and pregnancy outcome. Proc Nutr Soc 2002;61:45-50.
116. Langer O, Conway DL, Berkus MD, et al. A comparison of glyburide and insulin in women with gestational diabetes mellitus. . Engl J Med 2000;343: 1134-1138
117. Bochner CJ, Medearis AL, Williams J 3rd, et al. Early third-trimester ultrasound screening in gestational diabetes to determine the risk of macrosomia and labor dystocia at term. Am J Obstet Gynecol 1987;157:703-708.
118. Buchanan TA, Kjos SL, Montoro MN, et al. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care 1994;17:275-283.
119. Hod M, Bar J, Peled Y, et al. Antepartum management protocol. Timing and mode of delivery in gestational diabetes. Diabetes Care 1998;21[Suppl 2]: B113-B117.
120. Naylor CD, Sermer M, Chen E, et al. Cesarean delivery in relation to birth weight and gestational glucose tolerance: pathophysiology or practice style? Toronto Trihospital Gestational Diabetes Investigators. JAMA 1996;275:1165-1170.
121. Schaefer-Graf UM, Buchanan TA, Xiang A, et al. Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol 2000;182: 313-320.
122. Towner D, Kjos SL, Leung B, et al. Congenital malformations in pregnancies complicated by NIDDM. Diabetes Care 1995;18:1446-1451.
123. Kjos SL, Peters RK, Xiang A, et al. Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus. JAMA 1998;280:533-538.
124. Peters RK, Kjos SL, Xiang A, et al. Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet 1996;347:227-230.
125. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. . Engl J Med 2001;344:1343-1350.
126. Knowler WC, Barrett-Connor E, Fowler SE, et al: Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. . Engl J Med 2002;346:393-403.
127. Chiasson JL, Josse RG, Gomis R, et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002;359:2072-2077.
128. Buchanan TA, Xiang AH, Peters RK, et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 2002;51:2796-2803.
129. Pettitt DJ, Bennett PH. In: Reece EA, Coustan DR, eds. Diabetes mellitus in pregnancy: principles and practice. Churchill Livingstone: New York, 1995: 379-388.
130. Forman MR, Hoffman HJ, Harley EE, et al. The Pima infant feeding study: the role of sociodemographic factors in the trend in breast-and bottle-feeding. Am J Clin Nutr 1982;35:1477-1486.
131. Silverman BL, Landsberg L, Metzger BE. Fetal hyperinsulinism in offspring of diabetic mothers. Association with the subsequent development of childhood obesity. Ann N Y Acad Sci 1993;699:36-45.
132. Silverman BL, Metzger BE, Cho NH, et al. Impaired glucose tolerance in adolescent offspring of diabetic mothers. Relationship to fetal hyperinsulinism. Diabetes Care 1995;18:611-617.